| scholarly article | Q13442814 |
| P356 | DOI | 10.1309/980M-E24R-V19K-595D |
| P698 | PubMed publication ID | 10664627 |
| P2093 | author name string | Jacobs TW | |
| Schnitt SJ | |||
| Gown AM | |||
| Barnes MJ | |||
| Yaziji H | |||
| P4510 | describes a project that uses | immunohistochemistry | Q899285 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| immunohistochemistry | Q899285 | ||
| P304 | page(s) | 251-258 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | American Journal of Clinical Pathology | Q15750224 |
| P1476 | title | HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement | |
| P478 | volume | 113 |
| Q89116418 | A Transistor-like pH Nanoprobe for Tumour Detection and Image-guided Surgery |
| Q37625279 | A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals |
| Q92381156 | Accelerated instability testing reveals quantitative mass spectrometry overcomes specimen storage limitations associated with PD-L1 immunohistochemistry |
| Q36648916 | Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer |
| Q35440615 | Antigen retrieval immunohistochemistry: review and future prospects in research and diagnosis over two decades |
| Q37419479 | Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer. |
| Q57358066 | Cooperativity Principles in Self-Assembled Nanomedicine |
| Q81531277 | Correlation of the HER-2 protein expression and other clinicopathological features of ductal infiltrative breast cancer |
| Q73880965 | Detection of HER-2/neu gene amplification in breast cancer using a novel polymerase chain reaction/ligase detection reaction technique |
| Q54565355 | Detection of HER-2/neu gene amplification in breast carcinomas using quantitative real-time PCR - a comparison with immunohistochemical and FISH results. |
| Q61443166 | Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples |
| Q38455433 | Evaluation of HER-2/NEU protein expression in breast cancer by immunohistochemistry: an interlaboratory study assessing the reproducibility of HER-2/NEU testing |
| Q36644476 | Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas |
| Q39651684 | Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer |
| Q47126199 | HER-2/neu gene amplification in gastric adenocarcinoma and its relationship with clinical and pathological findings |
| Q43576640 | Herceptest: HER2 expression and gene amplification in non-small cell lung cancer |
| Q93000585 | PET imaging of occult tumours by temporal integration of tumour-acidosis signals from pH-sensitive 64Cu-labelled polymers |
| Q30885642 | Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study |
| Q34424285 | Testing for HER2 in Breast Cancer: A Continuing Evolution |
| Q36819669 | The effects of antibody clone and pretreatment method on the results of HER2 immunostaining in cytologic samples of metastatic breast cancer: A query and a review of the literature |
| Q37572252 | Uncertainty in the utility of immunohistochemistry in mismatch repair protein expression in epithelial ovarian cancer. |
| Q77582652 | Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II study |
Search more.